Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors.

Abnormal microvasculature contributes to the pathophysiologic microenvironment of tumors. Understanding microvascular tumor oxygen transport is necessary to comprehend the factors that influence tumor biology, physiology, and therapy. Previously, we described an in vivo spectral imaging microscopy system for measurements of microvessel hemoglobin saturation (HbSat). We measure temporal fluctuations and spatial gradients in tumor microvessel oxygenation and identify instances of anastomoses between vessels with significantly different oxygenations. Slow periodic fluctuations in HbSat <0.2 cycles per minute were observed. These measurements are consistent with microelectrode measurements of fluctuating tumor oxygenation. Gradients in HbSat along individual tumor microvessels were measured that were larger in magnitude than normal tissue microvessels. Images were captured of anastomoses of tumor microvessels with diameters <or=100 microm and significantly different HbSat values (>20%). Shunting of inspired oxygen, presumably due to arteriovenous anastomoses, from tumor feeding arterioles to adjacent venules was imaged. This effect was confined to a region around the tumor and was not observed in nearby normal microvessels. Imaging measurements of tumor microvessel oxygen transport may offer insight to current questions regarding oxygen-related tumor biology and treatment responses, and spectral imaging may be a useful research tool in this regard.

[1]  M. Dewhirst,et al.  Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. , 1999, American journal of physiology. Heart and circulatory physiology.

[2]  Rakesh K. Jain,et al.  Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.

[3]  M. Dewhirst,et al.  Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.

[4]  H. Dertinger,et al.  The Oxygen Effect , 1970 .

[5]  Axel R Pries,et al.  Angioadaptation: keeping the vascular system in shape. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[6]  H. Kontos,et al.  Vasomotion in cerebral microcirculation of awake rabbits. , 1988, The American journal of physiology.

[7]  Elizabeth A. Peck,et al.  Introduction to Linear Regression Analysis , 2001 .

[8]  R. Durand,et al.  Contribution of transient blood flow to tumour hypoxia in mice. , 1995, Acta oncologica.

[9]  P. Vaupel Tumor Blood Flow , 2000 .

[10]  S. McDougall,et al.  Mathematical modelling of flow through vascular networks: Implications for tumour-induced angiogenesis and chemotherapy strategies , 2002, Bulletin of mathematical biology.

[11]  M. Horsman,et al.  Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies. , 2006, Cancer research.

[12]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[13]  M. Dewhirst,et al.  Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. , 2005, Journal of biomedical optics.

[14]  P Vaupel,et al.  Modulation of tumor oxygenation. , 1998, International journal of radiation oncology, biology, physics.

[15]  E. Rofstad,et al.  Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  V. Grégoire,et al.  Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. , 2006, Cancer research.

[17]  Aoife M Shannon,et al.  Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. , 2003, Cancer treatment reviews.

[18]  S M Evans,et al.  Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia , 1999, British Journal of Cancer.

[19]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[20]  D. Siemann The tumor microenvironment: a double-edged sword. , 1998, International journal of radiation oncology, biology, physics.

[21]  D L Farkas,et al.  Near-simultaneous hemoglobin saturation and oxygen tension maps in mouse brain using an AOTF microscope. , 1997, Biophysical journal.

[22]  A. Li,et al.  Arteriovenous shunts in patients with hepatic tumors. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  M. Trotter,et al.  Therapeutic Significance of Microenvironmental Factors , 2000 .

[24]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[25]  Peter Vaupel,et al.  Blood Perfusion and Microenvironment of Human Tumors , 2000 .

[26]  M. Horsman,et al.  Modification of Oxygen Supply , 2000 .

[27]  M. Dewhirst Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. , 2007, Cancer research.

[28]  C. Koch,et al.  Quantitative spatial analysis of hypoxia and vascular perfusion in tumor sections. , 2003, Advances in experimental medicine and biology.

[29]  R. Berne,et al.  Longitudinal Gradients in Periarteriolar Oxygen Tension , 2005 .

[30]  Bruce Klitzman,et al.  Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. , 2006, Cancer research.

[31]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[32]  Timothy W Secomb,et al.  Tumor-dependent Kinetics of Partial Pressure of Oxygen Fluctuations during Air and Oxygen Breathing , 2004, Cancer Research.

[33]  M. Dewhirst,et al.  The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment. , 1993, British Journal of Cancer.

[34]  G. Schroth,et al.  Intratumoral Arteriovenous Shunting in Malignant Gliomas , 2001, Neurosurgery.

[35]  Michael Höckel,et al.  Hypoxia in breast cancer: role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion. , 2005, Advances in experimental medicine and biology.

[36]  G. Söderberg,et al.  Vascularization of fibromatous and fibrosarcomatous tumors , 1960 .

[37]  Brian S. Sorg,et al.  Measurement of hemoglobin saturation in tumor microvasculature in preclinical models using hyperspectral imaging , 2005, SPIE BiOS.

[38]  R. Edlich,et al.  Tumor Blood Flow , 1969, Angiology.

[39]  E. Rofstad,et al.  Fluctuating and Diffusion-Limited Hypoxia in Hypoxia-Induced Metastasis , 2007, Clinical Cancer Research.

[40]  M. Dewhirst,et al.  Variability in blood flow and pO2 in tumors in response to carbogen breathing. , 1998, International journal of radiation oncology, biology, physics.

[41]  M Intaglietta,et al.  Quantitation of rhythmic diameter changes in arterial microcirculation. , 1984, The American journal of physiology.

[42]  B. Reglin,et al.  An Imaging Spectroscopy Approach for Measurement of Oxygen Saturation and Hematocrit During Intravital Microscopy , 2007, Microcirculation.

[43]  M. Dewhirst,et al.  Concepts of oxygen transport at the microcirculatory level. , 1998, Seminars in radiation oncology.